These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 21635693)
1. Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments. Langford-Smith A; Malinowska M; Langford-Smith KJ; Wegrzyn G; Jones S; Wynn R; Wraith JE; Wilkinson FL; Bigger BW Genes Brain Behav; 2011 Aug; 10(6):673-82. PubMed ID: 21635693 [TBL] [Abstract][Full Text] [Related]
2. Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice. Lau AA; Crawley AC; Hopwood JJ; Hemsley KM Behav Brain Res; 2008 Aug; 191(1):130-6. PubMed ID: 18453006 [TBL] [Abstract][Full Text] [Related]
3. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126 [TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune activation in the brain of MPS IIIB mouse model. DiRosario J; Divers E; Wang C; Etter J; Charrier A; Jukkola P; Auer H; Best V; Newsom DL; McCarty DM; Fu H J Neurosci Res; 2009 Mar; 87(4):978-90. PubMed ID: 18951493 [TBL] [Abstract][Full Text] [Related]
5. Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test. Langford-Smith A; Langford-Smith KJ; Jones SA; Wynn RF; Wraith JE; Wilkinson FL; Bigger BW PLoS One; 2011; 6(10):e25717. PubMed ID: 22028789 [TBL] [Abstract][Full Text] [Related]
6. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery. Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Yogalingam G; Hopwood JJ Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611 [TBL] [Abstract][Full Text] [Related]
8. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice. Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887 [TBL] [Abstract][Full Text] [Related]
9. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Hemsley KM; Hopwood JJ Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885 [TBL] [Abstract][Full Text] [Related]
11. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Weber B; Guo XH; Kleijer WJ; van de Kamp JJ; Poorthuis BJ; Hopwood JJ Eur J Hum Genet; 1999 Jan; 7(1):34-44. PubMed ID: 10094189 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of exploration and risk assessment in pre-weaning mice using the novel cage test. Marques JM; Olsson IA; Ogren SO; Dahlborn K Physiol Behav; 2008 Jan; 93(1-2):139-47. PubMed ID: 17888463 [TBL] [Abstract][Full Text] [Related]
13. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810 [TBL] [Abstract][Full Text] [Related]
14. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B. Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481 [TBL] [Abstract][Full Text] [Related]
15. Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations. Bunge S; Knigge A; Steglich C; Kleijer WJ; van Diggelen OP; Beck M; Gal A J Med Genet; 1999 Jan; 36(1):28-31. PubMed ID: 9950362 [TBL] [Abstract][Full Text] [Related]
16. Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery. Fu H; Meadows AS; Ware T; Mohney RP; McCarty DM Mol Ther; 2017 Mar; 25(3):792-802. PubMed ID: 28143737 [TBL] [Abstract][Full Text] [Related]
17. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044 [TBL] [Abstract][Full Text] [Related]
18. Differential genetic regulation of motor activity and anxiety-related behaviors in mice using an automated home cage task. Kas MJ; de Mooij-van Malsen AJ; Olivier B; Spruijt BM; van Ree JM Behav Neurosci; 2008 Aug; 122(4):769-76. PubMed ID: 18729629 [TBL] [Abstract][Full Text] [Related]
19. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer. Villani GR; Follenzi A; Vanacore B; Di Domenico C; Naldini L; Di Natale P Biochem J; 2002 Jun; 364(Pt 3):747-53. PubMed ID: 12049639 [TBL] [Abstract][Full Text] [Related]
20. Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain. De Pasquale V; Costanzo M; Siciliano RA; Mazzeo MF; Pistorio V; Bianchi L; Marchese E; Ruoppolo M; Pavone LM; Caterino M Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]